Technical Analysis for HQL - H&Q Life Sciences Investors
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 15.55 | 0.06% | 0.01 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
New 52 Week High | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Stochastic Sell Signal | Bearish | 0.06% | |
Pocket Pivot | Bullish Swing Setup | 0.06% | |
Upper Bollinger Band Walk | Strength | 0.06% | |
Gapped Up | Strength | 0.06% |
Alert | Time |
---|---|
Rose Above Upper Bollinger Band | about 11 hours ago |
2x Volume Pace | about 11 hours ago |
1.5x Volume Pace | about 11 hours ago |
Upper Bollinger Band Resistance | about 11 hours ago |
Rose Above Previous Day's High | about 11 hours ago |
Get a Trading Assistant
- Earnings date: 08/06/2024
H&Q Life Sciences Investors Description
H&Q Life Sciences Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating in the health technology and life sciences industries. It also invests in stocks of early and later stage financings of privately held companies, private placements by public companies. The fund invests in growth stocks of companies operating across all market capitalizations. It employs fundamental analysis with a focus on factors such as potential for above-average, long-term growth in revenues and earnings securities strong market position for their services or products, experienced business management, and, recognized technological expertise. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Classification
Sector: Financial Services
Industry: Asset Management
Keywords: Stock Fund Business Management Health Technology Nasdaq Biotech Experienced Business Management
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 15.684 |
52 Week Low | 10.0622 |
Average Volume | 98,250 |
200-Day Moving Average | 13.29 |
50-Day Moving Average | 14.96 |
20-Day Moving Average | 15.16 |
10-Day Moving Average | 15.27 |
Average True Range | 0.23 |
RSI (14) | 65.28 |
ADX | 22.75 |
+DI | 27.52 |
-DI | 15.11 |
Chandelier Exit (Long, 3 ATRs) | 15.00 |
Chandelier Exit (Short, 3 ATRs) | 15.37 |
Upper Bollinger Bands | 15.66 |
Lower Bollinger Band | 14.65 |
Percent B (%b) | 0.89 |
BandWidth | 6.67 |
MACD Line | 0.17 |
MACD Signal Line | 0.13 |
MACD Histogram | 0.0409 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 15.85 | ||||
Resistance 3 (R3) | 15.86 | 15.77 | 15.80 | ||
Resistance 2 (R2) | 15.77 | 15.70 | 15.77 | 15.78 | |
Resistance 1 (R1) | 15.66 | 15.65 | 15.62 | 15.65 | 15.77 |
Pivot Point | 15.57 | 15.57 | 15.55 | 15.57 | 15.57 |
Support 1 (S1) | 15.46 | 15.50 | 15.42 | 15.45 | 15.33 |
Support 2 (S2) | 15.37 | 15.45 | 15.37 | 15.32 | |
Support 3 (S3) | 15.26 | 15.37 | 15.30 | ||
Support 4 (S4) | 15.25 |